Alibaba to Pay $600 Million to Settle US Probe Over Illegal Drug Sales
Quick Look
- Alibaba Group will pay $600 million to resolve a US Department of Justice investigation into allegations its platforms facilitated the sale of thousands of illegal pharmaceuticals and controlled substances into the US.
- The settlement involves non-prosecution agreements with Alibaba and AUS Merchant Services.
AI-generated summary
Alibaba Group will pay $600 million to resolve a US Department of Justice investigation into allegations its platforms facilitated the sale of thousands of illegal pharmaceuticals and controlled substances into the US. The settlement involves non-prosecution agreements with Alibaba and AUS Merchant Services.




